THERAVANCE BIOPHARMA US, INC.
Share on:
| Name: | THERAVANCE BIOPHARMA US, INC. |
| Jurisdiction: | New York |
| Legal type: | FOREIGN BUSINESS CORPORATION |
| Status: | Active |
| Date of registration: | 28 Aug 2014 (11 years ago) |
| Entity Number: | 4628528 |
| ZIP code: | 19901 |
| County: | New York |
| Place of Formation: | Delaware |
| Address: | 3500 SOUTH DUPONT HIGHWAY, DOVER, DE, United States, 19901 |
| Principal Address: | 901 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, United States, 94080 |
| Name | Role |
|---|---|
| Registered Agent Revoked | Agent |
| Name | Role | Address |
|---|---|---|
| INCORPORATING SERVICES, LTD. | DOS Process Agent | 3500 SOUTH DUPONT HIGHWAY, DOVER, DE, United States, 19901 |
| Name | Role | Address |
|---|---|---|
| RICK E WINNINGHAM | Chief Executive Officer | 901 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, United States, 94080 |
| Start date | End date | Type | Value |
|---|---|---|---|
| 2025-07-01 | 2025-07-01 | Address | 901 GATEWAY BLVD., SAN FRANCISCO, CA, 94080, USA (Type of address: Chief Executive Officer) |
| 2025-07-01 | 2025-07-01 | Address | 901 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080, USA (Type of address: Chief Executive Officer) |
| 2024-08-01 | 2024-08-01 | Address | 901 GATEWAY BLVD., SAN FRANCISCO, CA, 94080, USA (Type of address: Chief Executive Officer) |
| 2024-08-01 | 2024-08-01 | Address | 901 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080, USA (Type of address: Chief Executive Officer) |
| 2024-08-01 | 2025-07-01 | Address | 901 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080, USA (Type of address: Chief Executive Officer) |
| Filing Number | Date Filed | Type | Effective Date |
|---|---|---|---|
| 250701038567 | 2025-06-30 | CERTIFICATE OF TERMINATION | 2025-06-30 |
| 240801037045 | 2024-08-01 | BIENNIAL STATEMENT | 2024-08-01 |
| 220803002100 | 2022-08-03 | BIENNIAL STATEMENT | 2022-08-01 |
| 220420003139 | 2022-04-20 | CERTIFICATE OF CHANGE BY ENTITY | 2022-04-20 |
| 200810060415 | 2020-08-10 | BIENNIAL STATEMENT | 2020-08-01 |
This company hasn't received any reviews.
Date of last update: 25 Mar 2025
Sources: New York Secretary of State